How Transparent Tech can Improve the Image of the Life Science Industry
We speak to Lance Hill, CEO of Within3, about how life sciences companies should embrace the power of insights management throughout the total life-cycle of…
Pharma
The Role of Data Analytics in Improving Clinical Trials and Drug Discovery
The last decade has brought about many developments to genomics, stem cell research, cancer therapies and immunotherapy – to name just a few areas. Hand…
Creating Rare Connections
Leveraging Technology to Bridge the Gap between Patients and Pharma Patient populations for individual rare diseases are usually small and spread out across many geographies…
BioSamples – The Block Between Bench and Bedside
A 2018 survey conducted by the UK agency Medicines Discovery Catapult found that 80% of SMEs (small to medium sized biotechs) found accessing biosamples from…
Ending the Global Pandemic Starts with An Adaptable Supply Chain
The development of no less than five separate, highly effective vaccines against COVID-19 in less than a year is nothing short of miraculous. As the…
Digital Technologies: Pharma’s Answer to Achieving Net Zero Emissions?
In June of this year, the Pacific Northwest battled unprecedented “heat domes,” which climate scientists agree would not have occurred in the absence of man-made…
How AI and ML is Driving Value for Global Pharma Players
Today, we can enjoy innovations that were once considered science fiction, thanks to Data Science. Machine Learning (ML) and Artificial Intelligence (AI) have revolutionized the…
Leading Clinical Technology Providers Join Forces to Tackle Key Clinical Trial Pain Point
uMotif and Xperiome, a global healthtech company specialising in rare disease are to collaborate through a partnership that will bring value to both life science…
How Rep Relationships Open Digital Doors to HCPs
As the life sciences industry continues to embrace virtual interactions over the long term, digital is becoming more than just a way for field reps…
The Business of Biospecimen Procurement needs to be Revised
The journey of a biospecimen used for medical research begins with the donor and ends in a research laboratory. What happens between those two points…